Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2005
03/03/2005US20050049203 Nitrogenous heterocyclic derivative, medicinal composition containing the same, medical use thereof, and intermediate therefor
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening
03/03/2005US20050048149 Controlling weight, obesity; antidiabetic agents; using apple juice extract
03/03/2005US20050048137 Extract of plant dendrobii caulis and preparing process thereof
03/03/2005US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders
03/03/2005US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir
03/03/2005US20050048055 Use of CD40 engagement to alter T cell receptor usage
03/03/2005US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
03/03/2005US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine
03/03/2005US20050047998 Phosphoprotein target for insulin and its antagonists
03/03/2005US20050047958 Methods for sterilizing preparations of digestive enzymes
03/03/2005DE10334309A1 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung Substituted thiazol-Benzoisothiazoldioxidderivate, processes for their preparation and their use
03/03/2005CA2536435A1 Drug containing chymase inhibitor as the active ingredient
03/03/2005CA2536422A1 Use of colipase-lipase inhibitors in the preparation of a pharmaceutical composition in order to prevent obesity
03/03/2005CA2536089A1 Ppar modulators
03/03/2005CA2532020A1 6-(2,2,2-trifluoroethylamino)-7-chloro-2,3,4,5-tetrahydro-1h-benzo[d]azepine as a 5-ht2c receptor agonist
03/02/2005EP1510519A1 Pharmaceutical compositions comprising 2,3-diarylpyrazolo[1,5-B]pyridazine derivatives
03/02/2005EP1510218A1 Extract of plant dendrobii caulis and preparing process thereof
03/02/2005EP1510208A1 Pharmaceutical composition comprising a combination of metformin and statin
03/02/2005EP1510137A1 Pyruvate enriched onion extract
03/02/2005EP1509621A1 Treatment with cytokines for alzheimer's disease
03/02/2005EP1509618A2 Autoimmune conditions and nadph oxidase defects
03/02/2005EP1509549A1 Extraction of unmilled psyllium
03/02/2005EP1509541A2 Novel recombinant anticoagulant proteins
03/02/2005EP1509532A1 1-thia-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
03/02/2005EP1509526A2 Imidazo(1,2-a)pyrazin-8-ylamines, method of making, and method of use thereof
03/02/2005EP1509524A1 Xanthine phosphodiesterase v inhibitor polymorphs
03/02/2005EP1509509A1 Glucagon antagonists/inverse agonists
03/02/2005EP1509506A1 Pyridazine derivatives
03/02/2005EP1509504A1 7-phenylsulfonyl-tetrahydro-3-benzazepine derivatives as antipsychotic agents
03/02/2005EP1509498A1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
03/02/2005EP1509497A1 Calcium receptor modulating arylalkylamines
03/02/2005EP1509495A1 Anilino liver x-receptor modulators
03/02/2005EP1509489A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509249A2 Inclusion complexes of rosiglitazone
03/02/2005EP1509239A2 Composition and method for reducing post-prandial blood glucose
03/02/2005EP1509237A2 Methods of treating angiogenesis, tumor growth, and metastasis
03/02/2005EP1509227A1 A buffered, liquid nicotine composition for pulmonary administration
03/02/2005EP1509223A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
03/02/2005EP1509212A1 Novel chromium (iii) alpha amino acid complexes
03/02/2005EP1509188A2 Compounds active at the glucocorticoid receptor ii
03/02/2005EP1421115B1 Soluble t cell receptor
03/02/2005EP1416966A4 Methods for treating joint inflammation, pain, and loss of mobility
03/02/2005EP1180102B9 Mutual prodrugs of amlodipine and atorvastatin
03/02/2005EP1129084B1 Thiazole derivatives as ppar gamma ligands
03/02/2005EP1014976B1 Novel substituted imidazole compounds
03/02/2005EP0991636B1 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
03/02/2005EP0948499B1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
03/02/2005EP0844873B1 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same
03/02/2005CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes
03/02/2005CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function
03/02/2005CN1589260A Heterocyclic compounds and methods of use thereof
03/02/2005CN1589258A Novel beta -phenyl- alpha -oxysubstituted propionic derivatives: process for their preparation and their use in the preparation of pharmaceutically important compounds
03/02/2005CN1589148A Succinic acid salts of 5, 8, 14-triazatetracyclo'10.3.1.0 less than2, 11greater than.0 less than 4, 9 greater than-hexadeca-2(11), 3, 5, 7, 9-pentaene and pharmaceutical compositions thereof
03/02/2005CN1589147A Use of N-(indolecarbonyl-)piperazine derivatives
03/02/2005CN1589108A Oilseed processing
03/02/2005CN1587369A Buck-wheat flavone vinega soft capsule and preparing method
03/02/2005CN1587269A Medicinal composition containing angiotensin II receptor antagonist and vitamin B
03/02/2005CN1586615A Starfish and seaweed compound product and its preparing method
03/02/2005CN1586598A Wuqi fat regulation oral liquid
03/02/2005CN1586589A Ginseng stem and leaf total saponin oral disintegration tablet and its preparing method
03/02/2005CN1586580A Pill for fat reducing
03/02/2005CN1586579A Medicine for treating diabetes
03/02/2005CN1586574A Medicine for reducing blood lipid
03/02/2005CN1586551A Rye-red yeast vinegar soft capsule and its preparing method
03/02/2005CN1586544A Medicinal wine and its producing method
03/02/2005CN1586529A Chinese medicine for health preserving and fat reducing by umbilical treatment
03/02/2005CN1586471A Silibinin meglumine salt oral disintegration tablet preparation and its preparing method
03/02/2005CN1191371C Process for preparing easy body absorption protein iron and health food produced therefrom
03/02/2005CN1191273C Long lasting insulinotropic peptides
03/02/2005CN1191251C Intermediate for preparing cyclopentane formamide compound and its preparation method
03/02/2005CN1191240C Nitrogen monoxide synthase inhibitor, its preparation method and application
03/02/2005CN1191236C Substituted 6,6-Hetero-dicycloderivative
03/02/2005CN1191233C N-substituted nitrogen heterocyclic compound
03/02/2005CN1191076C Medicine specially for treating diabetes
03/02/2005CN1191075C Composition and method for increasing weight gain and feed efficiency
03/02/2005CN1191070C Osteoblast-specific mitogens and drugs contining such compounds
03/01/2005US6861554 Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
03/01/2005US6861519 Soluble highly branched glucose polymers and their method of production
03/01/2005US6861447 Method for producing a coenzyme Q10/γ-cyclodextrin complex
03/01/2005US6861444 Treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; adrenergic blocking agents
03/01/2005US6861440 Antidiabetic agents
03/01/2005US6861429 2,3-diaryl-pyrazolo[1,5-b]pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (COX-2) inhibitors
03/01/2005US6861425 Benzimidazole compounds as ORL1-receptor agonists
03/01/2005US6861418 Modulating protein kinase signal transduction; anticancer agents
03/01/2005US6861417 Such as 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazine for treating cytokine mediated diseases such as psoriatic arthritis
03/01/2005US6861409 Compounds for use in the dtreatment of growth metabolic disorders
03/01/2005US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor
03/01/2005US6861404 Therapies for chronic renal failure
03/01/2005US6861256 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
03/01/2005US6861233 Method of screening for triacyglycerol hydrolase inhibitors
03/01/2005CA2196174C Use of ketoconazole and related substances in medicaments for treatment of type ii diabetes
02/2005
02/24/2005WO2005016928A1 Imidazopyridine derivatives
02/24/2005WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors
02/24/2005WO2005016881A1 Bicyclic indoline sulfonamide derivatives
02/24/2005WO2005016514A2 Combinatorial synthesis on support
02/24/2005WO2005016345A1 Multivitamin syrup for children or young adults
02/24/2005WO2005016335A1 Indoline-sulfanilic acid amides used as ppar delta modulators
1 ... 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 ... 1298